Irisin reduces bone fracture by facilitating osteogenesis and antagonizing TGF-β/Smad signaling in a growing mouse model of osteogenesis imperfecta
Objective: Osteogenesis imperfecta (OI) is a congenital disorder characterized by muscle defect and skeletal fragility, and no cure is yet available. Crosstalk between bone and muscle has become a new coming focus of therapeutic strategy in OI. Irisin, a secreted myokine, was found to be involved in...
Main Authors: | Bin Sun, Huiqiao Wu, Jiajia Lu, Rongcheng Zhang, Xiaolong Shen, Yifei Gu, Changgui Shi, Ying Zhang, Wen Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Journal of Orthopaedic Translation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214031X22001176 |
Similar Items
-
OSTEOGÉNESIS IMPERFECTA
by: Angélica Ibáñez, et al.
Published: (2021-05-01) -
Severe osteogenesis imperfecta: case report
by: Fernando Bastos, et al.
Published: (2010-12-01) -
Severe osteogenesis imperfecta: case report
by: Fernando Bastos, et al.
Published: (2010-12-01) -
Osteogenesis imperfecta
by: Justin Easow Sam, et al.
Published: (2017-01-01) -
Perinatal lethal osteogenesis imperfecta
by: Shahida Moosa
Published: (2012-11-01)